SEC Form 4 · accession 0001225208-26-006777
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wayne Markowitz
Officer — CVP, JAPAC
Period of report
Jul 28, 2026
Accepted (ET)
Jul 28, 2026 · 7:40 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 28, 2026 | M | 9,628 | $74.02 | A | 31,308 | D | |
| Common Stock | Jul 28, 2026 | S | 9,628 | $85.06 | D | 21,680 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Acquire) | $74.02 | Jul 28, 2026 | M | 9,628 | D | Sep 14, 2024 | Sep 13, 2030 | Common Stock | 9,628 | 9,628 | D |
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.